Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9887792 | Biochimie | 2005 | 4 Pages |
Abstract
Human tRNA3Lys is used by HIV virus as a primer for the reverse transcription of its genome. The 18 nucleotides at the 3â²-end of the tRNA3Lys are hybridized to a complementary sequence of the viral RNA called the primer-binding site. A screen against the human tRNA3Lys over a peptide library designed to target RNA has been performed. Of the 175 hexapeptides tested, three were found to bind to the d-stem of tRNA3Lys. Alanine-scanning was used to define the determinants of the interaction between the peptides and tRNA3Lys. They also bind to two other tested tRNAs, also at the level of the d-stem and loop, although the nucleotide sequence of the stem differs in one of them. These short peptides thus recognize specific structural features within the d-stem and loop of tRNAs. Associated with other pharmacophores, they could be useful to design optimized ligands targeting specific tRNAs such as retroviral replication primers.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Carine Tisné, Florence Guillière, Frédéric Dardel,